How common is moyamoya disease?
Moyamoya disease is a rare condition, affecting only about one in a million people, in which certain arteries at the base of the brain are constricted and blood flow in the brain is blocked.
How many cases does Moyamoya have?
Moyamoya disease was first identified in Japan, where it is most prevalent, affecting about 5 in 100,000 individuals. The condition is also relatively common in other Asian populations. It is ten times less common in Europe. In the United States, Asian Americans are four times more commonly affected than whites.
Are you born with moyamoya disease?
Moyamoya disease may occur at any age, though symptoms most commonly occur between 5 and 10 years of age in children and between 30 and 50 years of age in adults. Moyamoya disease causes different symptoms in adults and children.
What is Maui Maui disease?
Moyamoya disease is a chronic and progressive condition of the arteries in the brain. People with moyamoya disease have narrowing of these blood vessels that leads to blockages and can eventually cause ischemic stroke, hemorrhagic stroke, and seizures.
What triggers moyamoya?
The cause of moyamoya disease is unknown. The narrowing of the brain’s blood vessels may be due to injuries or genetic abnormalities. There may be some links between the condition and neurofibromatosis, or to procedures such as X-rays of the skull or heart surgery, or treatments such as chemotherapy.
Can moyamoya be cured?
Moyamoya is a progressive disease that does not improve without treatment. While moyamoya itself is not curable, surgery to provide alternative blood flow to the brain prevents the symptoms related to moyamoya and can provide an excellent long term outcome with significant stroke risk reduction.
Is moyamoya disease curable?
Doctors will evaluate your condition and determine the most appropriate treatment for your condition. Treatment doesn’t cure moyamoya disease but can be very effective in preventing strokes.
What is the difference between Moyamoya syndrome and moyamoya disease?
Moyamoya disease is distinct from moyamoya syndrome. In moyamoya syndrome, patients have a similar radiographic appearance of blood vessels, but the narrowing is caused by different mechanisms than the genetic mutation that leads to moyamoya disease. These mechanisms are important to discuss with your doctor.
What is the pathophysiology of moyamoya disease?
Moyamoya disease is a chronic cerebrovascular occlusive disease that is characterized by progressive stenosis of the terminal portion of the internal carotid artery and its main branches. The occurrence of Moyamoya disease is related to immune, genetic, and other factors.
What is the prevalence of multiple myeloma (MMD) in China?
The prevalence of MMD appears to be slightly lower among Chinese, compared to Koreans or Japanese. There are two peaks of incidence with different clinical presentations, at around 10 years and 30-40 years. The peak appears to occur later in women than men. In children, ischemic symptoms, especially transient ischemic attacks, are predominant.
What is the prevalence of myelodysplastic syndrome in Japan?
According to a survey performed in Japan in 1995, the prevalence of MMD was approximately 3.16/100,000, with an estimated incidence of 0.35/100,000 [7]. A subsequent survey in 2004 showed that the number of patients considerably increased, with an estimated incidence of 0.54/100,000, and prevalence of 6.03/100,000 in 2003 [8].
Can microbleeds predict subsequent cerebral hemorrhage in moyamoya disease?
The presence of multiple microbleeds as a predictor of subsequent cerebral hemorrhage in patients with moyamoya disease. Neurosurgery. 2008;62:104–111. [PubMed] [Google Scholar] 34.